K153584 is an FDA 510(k) clearance for the NeoTract UroLift System UL500. This device is classified as a Implantable Transprostatic Tissue Retractor System (Class II - Special Controls, product code PEW).
Submitted by Neotract, Inc. (Pleasanton, US). The FDA issued a Cleared decision on March 15, 2016, 91 days after receiving the submission on December 15, 2015.
This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5530. The Treatment Of Symptoms Due To Urinary Outflow Obstruction Secondary To Benign Prostatic Hyperplasia (bph) In Men Age 50 And Above..